{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:25:47Z","timestamp":1784640347405,"version":"3.55.0"},"reference-count":17,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe bleeding is a major complication in acute myeloid leukemia (AML), contributing to early mortality. While thrombocytopenia and coagulopathy are known risk factors, the clinical and laboratory features surrounding haemorrhagic events in real-world AML cohorts require further elucidation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the frequency, sites, clinical features, laboratory findings, and outcomes of Grade \u22653 bleeding in AML patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study reviewed 214 AML patients treated between 2012 and 2021 at a tertiary centre in Qatar. Patients with WHO Grade \u22653 bleeding were analysed for clinical, laboratory, cytogenetic, and outcome data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-five patients (16.3%) had Grade \u22653 bleeding, most commonly intracranial (86%), presenting with neurological symptoms (80%). Events occurred mainly during or soon after induction chemotherapy (40%). Median haemoglobin and platelet count at bleeding were 7.1\u2005g\/dL and 11\u2009\u00d7\u200910\n                      <jats:sup>9<\/jats:sup>\n                      \/L. Most cases (94%) were managed medically; 6% required neurosurgery. Thirty-day mortality was 41.2%, with overall mortality reaching 76.5%. Intracranial hemorrhage and septic shock accounted for most deaths.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Grade \u22653 bleeding, particularly intracranial, is a frequent and deadly event in AML, often arising during induction. Severe cytopenias and coagulopathy are common. Improved risk stratification and supportive care are essential to reduce bleeding-related mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10760296251405424","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T16:22:19Z","timestamp":1765383739000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["High-Risk Bleeding in Acute Myeloid Leukemia: Clinical Presentation, Laboratory Markers, and Mortality Trends"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-8455","authenticated-orcid":false,"given":"Mohammed","family":"Abdulgayoom","sequence":"first","affiliation":[{"name":"National Center for Cancer Care and Research, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Al-Asa'd","sequence":"additional","affiliation":[{"name":"Hamad General Hospital, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ali","sequence":"additional","affiliation":[{"name":"Hamad General Hospital, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1393-5302","authenticated-orcid":false,"given":"Abdulrahman F","family":"Al-Mashdali","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawra","family":"Shawaylia","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Sameh Soliman","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena","family":"Mudawi","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feryal","family":"Abbas","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omran","family":"Almokdad","sequence":"additional","affiliation":[{"name":"Hamad General Hospital, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Ellahie","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honar","family":"Cherif","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehab","family":"Mohamed","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research, HMC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"1","key":"e_1_3_3_2_2","first-page":"1","article-title":"Acute myeloid leukaemia","volume":"2","author":"Khwaja A","unstructured":"Khwaja A, Bjorkholm M, Gale RE, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016 Mar 10;2(1):1\u201322.","journal-title":"Nat Rev Dis Primers."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2024.2425051"},{"issue":"11","key":"e_1_3_3_4_2","first-page":"1530","article-title":"The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia","volume":"91","author":"Webert K","unstructured":"Webert K, Cook RJ, Sigouin CS, Rebulla P, Heddle NM. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica. 2006 Jan 1;91(11):1530\u20131537.","journal-title":"Haematologica"},{"key":"e_1_3_3_5_2","first-page":"094","volume-title":"Seminars in Thrombosis and Hemostasis","author":"Franchini M","unstructured":"Franchini M, Frattini F, Crestani S, Bonfanti C. Bleeding complications in patients with hematologic malignancies. In: Seminars in Thrombosis and Hemostasis, Vol. 39, No. 01. Thieme Medical Publishers; 2013 Feb:094\u2013100."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15074"},{"key":"e_1_3_3_7_2","first-page":"71","volume-title":"How to Manage Acquired Bleeding Disorders","author":"De Stefano V","unstructured":"De Stefano V, Castaman G. Bleeding risk and its management in acute leukemia. In: How to Manage Acquired Bleeding Disorders. Springer Nature Switzerland; 2025 Jun 19:71\u201382."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34728"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01293-x"},{"key":"e_1_3_3_10_2","article-title":"Mechanisms and management of coagulopathy in acute promyelocytic leukemia","volume":"164","author":"David S","unstructured":"David S, Mathews V. Mechanisms and management of coagulopathy in acute promyelocytic leukemia. Thromb Res. 2018 Apr 1;164(Suppl 1):S82\u2013S88.","journal-title":"Thromb Res."},{"issue":"1","key":"e_1_3_3_11_2","first-page":"46","article-title":"Acute myeloid leukemia management and research in 2025","volume":"75","author":"Kantarjian HM","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, et al. Acute myeloid leukemia management and research in 2025. CA Cancer J Clin. 2025 Jan;75(1):46\u201367.","journal-title":"CA Cancer J Clin."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006166"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn755"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-551507"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05466-1"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010118"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137741"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251405424","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10760296251405424","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251405424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:05:31Z","timestamp":1777385131000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10760296251405424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":17,"alternative-id":["10.1177\/10760296251405424"],"URL":"https:\/\/doi.org\/10.1177\/10760296251405424","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"10760296251405424"}}